|
MYST4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.351500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.625960E-01 |
| Normal-vs-Stage2 |
1.690760E-01 |
| Normal-vs-Stage3 |
1.559920E-03 |
| Normal-vs-Stage4 |
2.496100E-02 |
| Stage1-vs-Stage2 |
6.924600E-01 |
| Stage1-vs-Stage3 |
1.332200E-02 |
| Stage1-vs-Stage4 |
2.279600E-01 |
| Stage2-vs-Stage3 |
1.590990E-01 |
| Stage2-vs-Stage4 |
4.972000E-01 |
| Stage3-vs-Stage4 |
5.029400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.383100E-03 |
| Normal-vs-AfricanAmerican |
3.728400E-01 |
| Normal-vs-Asian |
3.719400E-01 |
| Caucasian-vs-AfricanAmerican |
5.264800E-01 |
| Caucasian-vs-Asian |
2.557200E-01 |
| AfricanAmerican-vs-Asian |
8.553200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.064700E-03 |
| Normal-vs-Female |
6.033900E-02 |
| Male-vs-Female |
1.476580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.673800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.541740E-02 |
| Normal-vs-Age(61-80Yrs) |
1.568210E-02 |
| Normal-vs-Age(81-100Yrs) |
6.064000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.493750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.111780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.929900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.610600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.843410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.753250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.771000E-04 |
| Classical-VS-Follicular |
4.725000E-01 |
| Classical-VS-Other |
9.878000E-01 |
| Classical-VS-Normal |
1.482040E-01 |
| Tall-VS-Follicular |
1.916340E-02 |
| Tall-VS-Other |
3.077400E-01 |
| Tall-VS-Normal |
1.986500E-04 |
| Follicular-VS-Other |
8.363000E-01 |
| Follicular-VS-Normal |
8.967800E-02 |
| Other-VS-Normal |
5.664600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.233500E-02 |
| Normal-vs-N1 |
6.675100E-03 |
| N0-vs-N1 |
1.849840E-01 |
|
|
